Castle Biosciences Inc (NAS:CSTL)
$ 24.37 0.63 (2.65%) Market Cap: 672.79 Mil Enterprise Value: 458.63 Mil PE Ratio: 0 PB Ratio: 1.67 GF Score: 79/100

Castle Biosciences Inc at Needham Healthcare Conference (Virtual) Transcript

Apr 12, 2022 / 07:00PM GMT
Release Date Price: $27.65 (-10.58%)
Mike Matson
Needham & Company, LLC - Analyst

All right, good afternoon. Thanks for joining us again at the 21st Annual Needham Healthcare Conference. I'm Mike Matson, senior research analyst on the med tech and diagnostics team. Next up, we have a presentation from Castle Biosciences.

Presenting from Castle is CEO Derek Maetzold, CFO Frank Stokes, and Vice President Investor Relations and Corporate Affairs Camilla Zuckero. We'll start with the presentation, and then we are going to leave some time for Q&A. (Conference Instructions)

So with that, I'll turn it over to Castle.

Derek Maetzold
Castle Biosciences, Inc. - Founder, President, & CEO

Off mute is probably better, right? (laughter) Thank you, Mike, for the introduction and for the Needham team in organizing such a great conference here on April 12.

So let me kind of walk through a limited part of our presentation here. I guess if you want to take away one thing from Castle, we are focused on really transforming disease management. And I'll walk through what our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot